The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1.
Open accessAbstract
Recent studies have demonstrated the existence of a soluble fibroblast growth factor (FGF) receptor type 1 (FGFR1) extracellular domain in the circulation and in vascular basement membranes. However, the process of FGFR1 ectodomain release from the plasma membrane is not known. Here we report that the 72-kDa gelatinase A (matrix metalloproteinase type 2, MMP2) can hydrolyze the Val368-Met369 peptide bond of the FGFR1 ectodomain, eight amino acids upstream of the transmembrane domain, thus releasing the entire extracellular domain. Similar results were obtained regardless of whether FGF was first bound to the receptor or not. The action of MMP2 abolished binding of FGF to an immobilized recombinant FGFR1 ectodomain fusion protein and to Chinese hamster ovary cells overexpressing FGFR1 The released recombinant FGFR1 ectodomain was able to bind FGF after MMP2 cleavage, suggesting that the cleaved soluble receptor maintained its FGF binding capacity. The activity of MMP2 could not be reproduced by the 92-kDa gelatinase B (MMP9) and was inhibited by tissue inhibitor of metalloproteinase type 2. These studies demonstrate that FGFR1 may be a specific target for MMP2 on the cell surface, yielding a soluble FGF receptor that may modulate the mitogenic and angiogenic activities of FGF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matrix metalloproteinases and their inhibitors in connective tissue remodeling
Woessner, J. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.8.1850705 · Cited by 3,282
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
Liotta, L. A., Steeg, P. S., & Stetler-Stevenson, W. G. (1991) · Cell · doi:10.1016/0092-8674(91)90642-c · Cited by 2,720
A matrix metalloproteinase expressed on the surface of invasive tumour cells
Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., & Seiki, M. (1994) · Nature · doi:10.1038/370061a0 · Cited by 2,551
Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., & Ornitz, D. M. (1991) · Cell · doi:10.1016/0092-8674(91)90512-w · Cited by 2,440
Self-citationTHE HEPARIN-BINDING (FIBROBLAST) GROWTH FACTOR FAMILY OF PROTEINS
Burgess, W. H., & Maciag, T. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.003043 · Cited by 1,928
Metalloproteinases and their inhibitors in matrix remodeling
Matrisian, L. M. (1990) · Trends in Genetics · doi:10.1016/0168-9525(90)90126-q · Cited by 1,605
Requirement of Heparan Sulfate for bFGF-Mediated Fibroblast Growth and Myoblast Differentiation
Rapraeger, A. C., Krufka, A., & Olwin, B. B. (1991) · Science · doi:10.1126/science.1646484 · Cited by 1,508
Structural and Functional Diversity in the FGf Receptor Multigene Family
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60821-0 · Cited by 1,250
Processing of tumour necrosis factor-α precursor by metalloproteinases
Gearing, A. J. H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., et al. (1994) · Nature · doi:10.1038/370555a0 · Cited by 1,194
The Fgf Family of Growth Factors and Oncogenes
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60305-x · Cited by 1,145
Folkman, J., & Shing, Y. (1992) · PubMed · Cited by 789
The kit ligand: A cell surface molecule altered in steel mutant fibroblasts
Flanagan, J. G., & Leder, P. (1990) · Cell · doi:10.1016/0092-8674(90)90299-t · Cited by 748
Ornitz, D. M., Yayon, A., Flanagan, J. G., Svahn, C. M., Levi, E., & Leder, P. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.240 · Cited by 632
Self-citationGoldberg, G. I., Marmer, B. L., Grant, G. A., Eisen, A. Z., Wilhelm, S., & He, C. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8207 · Cited by 586
Type IV collagenases in tumor invasion and metastasis
Stetler-Stevenson, W. G. (1990) · CANCER AND METASTASIS REVIEW · doi:10.1007/bf00049520 · Cited by 502
Ellis, V., Behrendt, N., & Danø, K. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98963-5 · Cited by 498
Takino, T., Sato, H., Shinagawa, A., & Seiki, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.23013 · Cited by 471
Complexity of FGF receptors: genetic basis for structural diversity and functional specificity
Givol, D., & Yayon, A. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.15.1464370 · Cited by 435
Self-citationHanemaaijer, R., Koolwijk, P., le Clercq, L., de Vree, W. J. A., & van Hinsbergh, V. W. M. (1993) · Biochemical Journal · doi:10.1042/bj2960803 · Cited by 378
Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman, R., Tóth, M., Peña, D., & Mobashery, S. (1995) · PubMed · Cited by 378
Self-citationFowlkes, J. L., Enghild, J. J., Suzuki, K., & Nagase, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47310-3 · Cited by 347
Monteagudo, C. C., Merino, M. J., Sanjuan, J., Liotta, L. A., & Stetler‐Stevenson, W. G. (1990) · Europe PMC (PubMed Central) · Cited by 322
Angiogenesis: role of calcium-mediated signal transduction.
Kohn, E. C., Alessandro, R., Spoonster, J., Wersto, R. P., & Liotta, L. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1307 · Cited by 288
Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism?
Vlodavsky, I., Bar-Shavit, R., Ishar-Michael, R., Bashkin, P., & Fuks, Z. (1991) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(91)90102-2 · Cited by 283
Self-citationPlasminogen activator and collagenase production by cultured capillary endothelial cells
Gross, J., Moscatelli, D., Jaffe, E., & Rifkin, D. (1982) · The Journal of Cell Biology · doi:10.1083/jcb.95.3.974 · Cited by 271
Galectin-3 Is a Novel Substrate for Human Matrix Metalloproteinases-2 and -9
Ochieng, J., Fridman, R., Nangia-Makker, P., Kleiner, D. E., Liotta, L. A., Stetler-Stevenson, W. G., & Raz, A. (1994) · Biochemistry · doi:10.1021/bi00251a020 · Cited by 265
Self-citationAviezer, D., Levy, E., Safran, M., Svahn, C., Buddecke, E., Schmidt, A., David, G., Vlodavsky, I., & Yayon, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42321-0 · Cited by 255
Self-citationGenetic analysis of proteoglycan structure, function and metabolism
Esko, J. D. (1991) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(91)90054-3 · Cited by 224
Binding and localization of M(r) 72,000 matrix metalloproteinase at cell surface invadopodia.
Monsky, W. L., Kelly, T. J., Lin, C. Y., Yeh, Y., Stetler‐Stevenson, W. G., Mueller, S. C., & Chen, W. T. (1993) · PubMed · Cited by 207
Ishai-Michaeli, R., Eldor, A., & Vlodavsky, I. (1990) · Cell Regulation · doi:10.1091/mbc.1.11.833 · Cited by 206
Self-citationFridman, R., Fuerst, T. R., Bird, R. E., Hoyhtya, M., Oelkuct, M., Kraus, S., Komarek, D., Liotta, L. A., Berman, M. L., & Stetler-Stevenson, W. G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49547-1 · Cited by 200
Self-citationThrombin Induces the Activation of Progelatinase A in Vascular Endothelial Cells
Zucker, S., Conner, C., DiMassmo, B. I., Ende, H., Drews, M., Seiki, M., & Bahou, W. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23730 · Cited by 177
A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor
Miyazaki, K., Hasegawa, M., Funahashi, K., & Umeda, M. (1993) · Nature · doi:10.1038/362839a0 · Cited by 175
Binding of plasminogen to extracellular matrix.
Knudsen, B. S., Silverstein, R. L., Leung, L. L., Harpel, P. C., & Nachman, R. L. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67452-6 · Cited by 173
Visscher, D. W., Höyhtyä, M., Ottosen, S. K., Liang, C., Sarkar, F. H., Crissman, J. D., & Fridman, R. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910590308 · Cited by 162
Self-citationYayon, A., Zimmer, Y., Shen, G. H., Avivi, A., Yarden, Y., & Givol, D. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05240.x · Cited by 160
Self-citationProteolysis of Aβ Peptide from Alzheimer Disease Brain by Gelatinase A
Roher, A. E., Kasunic, T. C., Woods, A. S., Cotter, R. J., Ball, M. J., & Fridman, R. A. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2872 · Cited by 135
Self-citationAlternative splicing generates at least five different isoforms of the human basic-FGF receptor.
Eisemann, A., Ahn, J.-K., Graziani, G., et al. (1991) · PubMed · Cited by 104
Ron, D., Reich, R., Chedid, M., Lengel, C. R., Cohen, O. E., Chan, A. M.-L., Neufeld, G., Miki, T., & Tronick, S. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53334-2 · Cited by 97
A novel form of FGF receptor‐3 using an alternative exon in the immunoglobulin domain III
Avivi, A., Yayon, A., & Givol, D. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80882-u · Cited by 97
Self-citationIdentification of soluble forms of the fibroblast growth factor receptor in blood.
Hanneken, A. M., Ying, W., LING, N. C., & Baird, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9170 · Cited by 94
Hanneken, A. M., Maher, P. A., & Baird, A. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.128.6.1221 · Cited by 89
Fridman, R., Bird, R. E., Höyhtyä, M., Oelkuct, M., Komarek, D., Liang, C., Berman, M. L., Liotta, L. A., Stetler‐Stevenson, W. G., & Fuerst, T. R. (1993) · Biochemical Journal · doi:10.1042/bj2890411 · Cited by 81
Self-citationBenezra, M., Vlodavsky, I., Yayon, A., Bar‐Shavit, R., Regan, J., Chang, M., & Ben-Sasson, S. (1992) · PubMed · Cited by 31
Self-citationHeparan sulfate primed on β‐D‐xylosides restores binding of basic fibroblast growth factor
Miao, H., Fritz, T. A., Esko, J. D., Zimmermann, J. J., Yayon, A., & Vlodavsky, I. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240570202 · Cited by 29
Self-citation
Cited by
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
“MMP2, for example, cleaves cell surface fibroblast growth factor (FGF) receptor 1 at a specific juxtamembrane site, thereby releasing a soluble receptor fragment that retains its ability to bind FGF (Levi et al. 1996).”
BackgroundInfluentialMatrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929
Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: The Good, the Bad, and the Ugly
Galis, Z. S., & Khatri, J. J. (2002) · Circulation Research · doi:10.1161/res.90.3.251 · Cited by 1,548
Matrix metalloproteinases: they're not just for matrix anymore!
McCawley, L. J., & Matrisian, L. M. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00248-9 · Cited by 1,274
Metadata
- Authors
- Levi, E., Fridman, R., Miao, H. Q., Ma, Y. S., Yayon, A., & Vlodavsky, I.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-07-09
- Volume
- 93
- Issue
- 14
- Pages
- 7069-7074
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2011111584
- Cited by
- 351
- References
- 45
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.